dr. wong on antibody-drug conjugate research in multiple myeloma
Published 4 years ago • 230 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
2:01
dr. wong on an investigational antibody-drug conjugate in multiple myeloma
-
2:16
dr. wong on a trial with an anti-cd46 antibody in myeloma
-
0:57
insights into a novel antibody-drug conjugate in myeloma: hdp-101
-
0:14
copy of dr. wong discusses the fda approval of elotuzumab triplet in myeloma
-
2:58
the promise of antibody-drug conjugates for the treatment of multiple myeloma
-
52:22
2/10/17: multiple myeloma: the good, the bad and the ugly
-
1:17
sanofi – antibody – drug conjugates
-
5:49
what are immunomodulatory drugs (imids) and how do they work?
-
3:40
antibody-drug conjugates in myeloma
-
0:59
dr. valent on ongoing research with immunotherapy in multiple myeloma
-
8:12
role of antibody drug conjugates and personal experience
-
6:20
what are antibody drug conjugates?
-
6:22
what are antibody drug conjugates?
-
16:32
new antibodies and antibody-drug conjugates for b-cell lymphoma
-
1:29
the future of adcs in treating multiple myeloma
-
56:32
antibody drug conjugates for cancer
-
1:58
dr. lonial on data with belantamab mafodotin in multiple myeloma
-
1:33
the role of allogeneic transplantation in patients with multiple myeloma
-
1:11
dr. lonial on daratumumab plus pomalidomide in multiple myeloma
-
1:25
rise of antibody-based treatments in myeloma
-
3:02
adcs for the treatment of myeloma
-
1:55
dr. biran on new agents and combos in relapsed multiple myeloma